NEW YORK, Sept. 5, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Medical Laboratories Industry
http://www.reportlinker.com/p0960414/Global-Medical-Laboratories-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
This report analyzes the worldwide markets for Medical Laboratories in US$ Million by the following Product Segments: Hospital-Based Medical Laboratories, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 162 companies including many key and niche players such as Adeona Clinical Laboratory, Alverno Clinical Laboratories, LLC, ARUP Laboratories, Asuragen, Inc., Bio-Reference Laboratories, Inc., Creative Testing Solutions, Gamma-Dynacare Medical Laboratories, Genoptix, Inc., Healthscope Ltd., Laboratory Corporation of America® Holdings, Metametrix Clinical Laboratory, Mayo Medical Laboratories, Medtox Scientific, Inc., The National Health Laboratory Service, Pathology, Inc., Quest Diagnostics, Inc., Quest Diagnostics Nichols Institute, Sonic Healthcare Ltd., American Esoteric Labs, Clinical Pathology Laboratories, Inc., Sonora Quest Laboratories, STAR Metropolis Clinical Laboratories & Health Services, and Thyrocare Technologies Limited. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Hospital-Based Medical Laboratories I-3
Others I-3
Physician's Office-Based Medical Labs I-3
Independent Laboratories I-4
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW II-1
Medical Laboratories: A Prelude II-1
Current and Future Analysis II-1
Analysis by Geographic Region II-1
US - The Largest Market for Medical Laboratories II-1
Asia-Pacific - High Potential Market for Medical Laboratories II-1
Analysis by Location of Medical Lab II-2
Hospital-Based Medical Laboratories - The Single Largest
Segment II-2
Other Medical Laboratories to Bolster Growth II-2
Impact of Recession II-2
A Snapshot of Global Market Opportunity II-3
Growth Drivers II-3
Rising Awareness Levels II-3
Need to Cut Healthcare Costs II-3
Aging Global Population II-3
Table 1: Over-65 Years Population as a % of Total
Population (2010 & 2020P) (includes corresponding
Graph/Chart) II-3
Increase in Healthcare Spending in Emerging Markets II-3
Other Growth Drivers II-4
Challenges II-4
Point-of-Care Testing Poses Stiff Challenge II-4
Dependence on Third Parties II-4
Lack of Skilled Workers II-4
Competitive Landscape II-5
Table 2: Major M&As in the Medical Laboratory Industry
(2010-2011) II-5
Noteworthy Market Trends II-6
Shortened Hospitalization Enhances Significance of Medical Labs II-6
Lab Automation Speeds Up II-6
Heightened Use of IT Systems in Clinical Laboratories II-6
Despite Challenges, Brazil, India, and China Emerge as Big
Markets II-7
Global Laboratory Outsourcing Industry: An Overview II-7
Legislative & Regulatory Environment Worldwide II-7
GCLP II-7
ISO 15189:2003 II-8
ISO 15189 Accreditation: Still in Infancy II-8
ILAC II-8
2. AN OVERVIEW OF MEDICAL LABORATORIES II-9
What is a Medical Laboratory? II-9
Anatomic Pathology II-9
Cytopathology/Cytology II-9
Electron Microscopy II-9
Histopathology II-9
Histology II-9
Physiology II-9
Pathology II-9
Pathophysiology II-9
Clinical Pathology II-9
Clinical Microbiology II-9
Clinical Chemistry II-10
Genetics II-10
Hematology II-10
Reproduction Biology II-11
Urinalysis II-11
Clinical Biochemistry II-11
Uses of Clinical Testing II-11
Types of Tests Conducted in Medical Labs II-11
Routine Tests II-11
Esoteric Tests II-12
Types of Medical Laboratories II-12
Hospital-Based Medical Laboratories II-12
Physician's Office-Based Medical Labs II-12
Reference Laboratories II-12
Potential Customers for Medical Laboratories by Type -
Hospital-Based, Physician's Office Based, and Other
Laboratories II-13
Economic Model Followed By Testing Laboratories II-13
Revenues II-13
Expenses II-14
Dichotomy between Customers and Payers in Medical Lab Industry II-14
Testing Equipment II-14
Bio-safety Hazards and Equipment Design II-14
Essential Bio-safety Equipment in Clinical Laboratories II-15
Personal Protection Equipment in Medical Labs II-15
The Work in Medical Laboratories II-16
Conduction of Lab Tests II-16
Role of Medical Technologists II-16
Role of Medical Technicians II-17
Analysis, Validation and Interpretation of Results II-17
Impact of Environmental Factors on Lab Tests II-18
Cleanliness II-18
Dust II-18
Humidity II-18
Temperature II-18
Light II-18
Seasonal Nature of Business II-18
Work Environment in Medical Labs II-19
Training and Education of Lab Personnel II-19
Career Advancement II-19
3. RECENT INDUSTRY ACTIVITY II-20
TrovaGene Acquires MultiGEN Diagnostics Clinical Laboratory
Business II-20
Quest Diagnostics Acquires S.E.D. Medical Laboratories II-20
Bode Technology Group Takes Over Chromosomal Laboratories II-20
Gamma-Dynacare Medical Laboratories and LifeLabs Ink
Definitive Agreement II-20
The University of Western Australia Establishes Translational
Cancer Pathology Laboratory II-21
Khandelwal Laboratories Establishes KLab in Nepal II-21
Becton, Dickinson and Company Takes Over KIESTRA Lab Automation II-21
Medizinisch Diagnostiche Institute to Upgrade Hospitals II-21
Enzo Clinical Labs Acquires Marketing Rights from IncellDx II-21
Gamma-Dynacare Medical Laboratories Takes Over Warnex Medical
Laboratories II-22
MediCap Holding Takes Over UAB Sorpo from Thermo Fisher
Scientific II-22
US Clinical Laboratories Acquires Vidalia Lab Services and
Augusta Laboratory II-22
Quest Diagnostics Acquires Athena Diagnostics II-22
Aviir Unveils Unique Cardiac Clinical Laboratory II-23
Miraculins Enters into PreVu Partnership with Gamma-Dynacare II-23
Mayo Medical Laboratories Inks Agreement with Rheonix II-23
Mayo Clinic Inks Strategic Collaboration Agreement with Wuhan
Kindstar Globalgene Technology II-24
Regional Medical Research Centre Unveils Two New Medical Labs II-24
Thermo Fisher Scientific to Divest Lancaster Laboratories II-24
Novartis International Acquires Genoptix II-24
Pathology Holdings Takes Over Central Coast Clinical Laboratories II-25
Sonic Healthcare Takes Over Woestyn Laboratory, KBL-BML-
Unilabo Laboratory and Physicians Automated Laboratory II-25
Addtech Life Science to Acquire Electra-Box Diagnostica II-25
Star Metropolis Clinic Laboratories Launches Advance
Diagnostic and Pathological Laboratory in Sharjah II-25
WisTa Laboratories and Bayer Schering Pharma Enter into
Collaborative R&D Agreement II-26
Addtech to Take Over Immuno Diagnostic II-26
Bio-Reference Laboratories Inks Definitive Agreement with
Massachusetts General Hospital II-26
InSight Health Services Holdings Takes Over Imaging Center in
Virginia II-26
Sonic Healthcare Acquires CBLPath II-27
Bangkok Dusit Medical Services Acquires ANB Laboratories II-27
Perceptronix Medical and Al Mokhtabar Laboratories Ink
Partnership Agreement II-27
Indus Health Plus Collaborates with Thyrocare Technologies II-27
Enzo Biochem and MultiGEN Diagnostics Ink Agreement II-27
Diagnosticos da Am'rica Inks MoU for Acquiring Stakes in MD1
Diagnosticos Subsidiaries II-28
GSTS Pathology Enters into Partnership with KingsPath II-28
Fujitsu Laboratories, Technology and Research (A*STAR) and
Fujitsu Asia Establish New Research Center II-28
Carilion Labs Merged with Spectrum Laboratory Network II-29
RadPharm Merges with Medifacts International II-29
LabCorp Takes Over DCL Medical Laboratories II-29
Mesa Laboratories Acquires SGM Biotech II-30
Bio-Reference Laboratories Takes Over Lenetix Medical
Screening Laboratory II-30
St. Jude Medical Takes Over LightLab Imaging II-30
Sonic Healthcare Acquires Medhold II-31
IRIS International Renames AlliedPath as Arista Laboratories II-31
Laboratory Corporation of America Holdings Acquires Genzyme
Genetics II-31
Laboratory Corporation of America Holdings to Acquire Diamond
Reference Laboratory and Westcliff Medical Laboratories II-31
ARUP Laboratories Inks Partnership with deCODE Genetics II-32
Warnex Collaborates with The Centre of Excellence in
Personalized Medicine and Montreal Heart Institute II-32
Sysmex America Enters into Agreement with Laboratory
Corporation of America Holdings II-32
Alverno Clinical Laboratories and CIGNA HealthCare Enter into
New Laboratory Service Agreement II-33
Sunrise Medical Laboratories and Elderplan Enter into New
Laboratory Agreement II-33
Genoptix and Aetna Enter into Three-Year Agreement II-33
California Laboratory Associates to Establish a Clinical Lab II-34
Rosetta Genomics Entered into Exclusive Distribution Agreement
with Warnex Medical Laboratories II-34
Bruker Daltonics and Limbach Laboratory Network Enter into
Novel Framework Agreement II-35
Catholic Health Initiatives, Pathology Associates Medical
Laboratories and Providence Health & Services Enter into
Partnership II-35
Florida Blood Services and Blood Systems Laboratories to Enter
Joint Venture II-35
Adeona Pharmaceuticals Inks Agreement to Take Over Hartlab II-36
MedLink International and Clinical Laboratory Management Ink
Affiliation Agreement II-36
The National Kidney and Transplant Institute Launches Total
Laboratory Automation Facility II-36
Metametrix Clinical Laboratories Takes Over AccuChem Laboratories II-37
Euromedic Acquires CIENTIA Laboratories II-37
Beckman Coulter Acquires Olympus II-37
ACM Global Central Laboratory Takes Over Pivotal Laboratories II-37
Covance and Merck & Co. Enter into Agreement II-37
Sonic Healthcare Takes Over East Side Clinical Laboratory II-38
Commonwealth Biotechnologies Divests Assets of Fairfax
Identity Laboratory and CBI Services to Bostwick Laboratories II-38
Sunquest Information Systems Takes Over Outreach Advantage
Solution Suite II-38
Charles River Laboratories to Take Over Piedmont Research Center II-39
Synlab Acquires United Medical Lab Riyadh II-39
ICON Takes Over Veeda Laboratories II-39
Lab21 Takes Over Biotec Laboratories II-39
Warnex Takes Over Molecular World II-40
Medica and Sysmex America Enter into Partnership Agreement II-40
LabCorp Inks Agreement with Centrex Laboratories II-40
4. ACCREDITATIONS/APPROVALS/ CERTIFICATIONS II-41
CombiMatrix Obtains New York Clinical Laboratory Permit II-41
OvaGene Oncology Obtains CLIA-Certification for Novel
Molecular Oncology Laboratory II-41
CSI Laboratories Granted Approval by COG II-41
Genzyme Genetics Receives CAP 15189SM Accreditation II-41
FDA Clears Foremost Test for Dengue II-42
Warnex Receives Accreditation from ASCLD/LAB- International® II-42
5. PRODUCT INNOVATIONS/INTRODUCTIONS II-43
Practice Fusion Unveils Lab API II-43
Sysmex America Introduces Sysmex WAM Select Middleware II-43
diaDexus Introduces CE marked PLAC Test for Lp-PLA(2) Activity II-43
Asuragen Introduces Diagnostic Kit for Fragile X Syndrome II-43
Pathology Holdings Launches JAK2 Mutation Analysis II-44
ARUP Laboratories Launches PAM50 Test for Classification of
Breast Cancer II-44
Pathology Holdings Launches New Testing for Herpes Simplex
Virus Detection II-44
Quest Diagnostics Launches OVA1TM Blood Test II-45
ARUP Laboratories Releases Calculators for Cost Saving Treatment II-45
ARUP Laboratories and AB SCIEX to Develop QTRAP® 5500 Mass
Spectrometry Technology II-45
Molecular Imaging Labs and TU Delft Develop 'Versatile
Emission Computed Tomography' Device II-46
Perceptronix Medical Redesigns ClearCyte™ Cytology Platform II-46
Asuragen Introduces BRAF and KRAS Mutational Testing II-46
Mayo Medical Laboratories and VitalHealth to Launch Electronic
Health Record Product II-47
Fletcher-Flora Health Care Systems Introduces FFlex eSuite MGR
Laboratory Information System II-47
American Esoteric Labs Launches ImmunoCAP® Specific IgE Blood
Test for Allergic Diseases II-47
Metametrix Clinical Laboratory Introduces New Testing Profiles
for Toxicity II-48
Metametrix Clinical Laboratory Launches Non-invasive TRIAD
Bloodspot Profile II-48
Roche Diagnostics Canada Unveils cobas® 4800 Clinical
Laboratory System II-49
6. FOCUS ON SELECT GLOBAL PLAYERS II-50
Adeona Clinical Laboratory (US) II-50
Alverno Clinical Laboratories, LLC (US) II-50
ARUP Laboratories (US) II-50
Asuragen, Inc. (US) II-51
Bio-Reference Laboratories, Inc. (US) II-51
Creative Testing Solutions (US) II-52
Gamma-Dynacare Medical Laboratories (Canada) II-52
Genoptix, Inc. (US) II-53
Healthscope Ltd. (Australia) II-53
Laboratory Corporation of America® Holdings (US) II-53
Metametrix Clinical Laboratory (US) II-55
Mayo Medical Laboratories (Canada) II-55
Medtox Scientific, Inc. (US) II-55
The National Health Laboratory Service (South Africa) II-56
Pathology, Inc. (US) II-56
Quest Diagnostics, Inc. (US) II-56
Quest Diagnostics Nichols Institute (US) II-57
Sonic Healthcare Ltd. (Australia) II-58
American Esoteric Labs (US) II-58
Clinical Pathology Laboratories, Inc. (US) II-58
Sonora Quest Laboratories (US) II-58
STAR Metropolis Clinical Laboratories & Health Services (UAE) II-59
Thyrocare Technologies Limited (India) II-59
7. GLOBAL MARKET PERSPECTIVE II-60
Table 3: World Recent Past, Current and Future Analysis for
Medical Laboratories by Geographic Region/Country - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America, and Rest of World Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) II-60
Table 4: World Historic Review for Medical Laboratories by
Geographic Region/Country - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America, and Rest of
World Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-61
Table 5: World 15-Year Perspective for Medical Laboratories by
Geographic Region/Country - Percentage Breakdown of Revenues
for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America, and Rest of World Markets for Years 2004, 2011
and 2018 (includes corresponding Graph/Chart) II-62
Table 6: World Recent Past, Current and Future Analysis for
Hospital-Based Medical Laboratories by Geographic
Region/Country - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) II-63
Table 7: World Historic Review for Hospital-Based Medical
Laboratories by Geographic Region/Country - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America, and
Rest of World Markets Independently Analyzed with Annual
Revenue Figures in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) II-64
Table 8: World 15-Year Perspective for Hospital-Based Medical
Laboratories by Geographic Region/Country - Percentage
Breakdown of Revenues for US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America, and Rest of
World Markets for Years 2004, 2011 and 2018 (includes
corresponding Graph/Chart) II-65
Table 9: World Recent Past, Current and Future Analysis for
Other Medical Laboratories by Geographic Region/Country - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America and Rest of World Markets Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) II-66
Table 10: World Historic Review for Other Medical Laboratories
by Geographic Region/Country - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America, and Rest of
World Markets Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-67
Table 11: World 15-Year Perspective for Other Medical
Laboratories by Geographic Region/Country - Percentage
Breakdown of Revenues for US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America, and Rest of
World Markets for Years 2004, 2011 and 2018 (includes
corresponding Graph/Chart) II-68
III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Medical and Diagnostic Laboratories Market: An Overview III-1
Laboratory Testing Accounts for Paltry Share in National
Healthcare Spending III-2
Table 12: US Medical Laboratories Market (2009): Percentage
Share Breakdown of Total Healthcare Expenditure by Segment -
Hospital Care, Physician/ Clinical, Prescription Drugs,
Nursing Home, Dental Services, Laboratory Testing, and
Others (includes corresponding Graph/Chart) III-2
Lab Testing Industry Displays Positive Trend Post-Recession III-2
Growth Drivers III-3
Demographics III-3
Table 13: US Population Breakdown by Age Group (2011) (
includes corresponding Graph/Chart) III-3
Introduction of Novel Healthcare IT Solutions III-3
Scientific and Technological Advances III-3
Increased Prevalence and Incidence of Diseases III-4
Increased Focus on Prevention and Wellness III-4
Growing Focus on Early Screening III-4
Need to Reduce Healthcare Costs III-4
Companies Moving Outside Local Turf III-4
Legislative, Regulatory and Policy Environment III-4
Opportunities in Personalized Medicine and Clinical Trial
Services III-4
Shortened Hospital Stay Enhances Significance of Medical Labs III-5
Esoteric Testing Market on a Roll III-5
Tissue-Based Diagnostics Market to Expand III-5
Proposal to Ensure Direct Patient Access to Lab Test Results III-5
Competitive Landscape III-6
By Provider Type III-6
Table 14: US Medical Laboratories Market (2010):
Percentage Share Breakdown of Market Share of Laboratory
Industry by Test Volume by Segment - Hospital-Based,
Independent, Physician's Office-Based, and Others
(includes corresponding Graph/Chart) III-6
Hospital-Based Labs III-6
Independent Labs III-7
Physician Office-Based Labs and Others III-7
By Player Size III-7
Table 15: M&A Activity in the US Clinical Laboratory
Market (2009-2011) III-8
Reimbursement Scenario for Clinical Laboratory Tests in the US III-9
Medicare Coverage for Screening Tests III-9
Medicare Clinical laboratory Fee Schedule III-10
Medicare Physician Fee Schedule (MPFS) III-10
Medicaid III-10
Regulatory Scenario in the US III-11
Various Accreditations and Certifications Available for
American Medical Labs III-11
A2LA III-11
ASCLS III-11
CAP III-11
CLIA III-12
Table 16: US Medical Laboratories Market (2011):
Percentage Share Breakdown of Number of Medical
Laboratories by CLIA Certificate Type (Non-Exempt Only) -
Waiver, Provider Performed Microscopy, Compliance, and
Accreditation (includes corresponding Graph/Chart) III-13
Table 17: US Medical Laboratories Market (2011):
Percentage Share Breakdown of Number of Physician's
Office-Based Medical Laboratories by CLIA Certificate
Type (Non-Exempt Only) - Waiver, Provider Performed
Microscopy, Compliance, and Accreditation (includes
corresponding Graph/Chart) III-13
Table 18: US Medical Laboratories Market (2011):
Percentage Share Breakdown of Number of CLIA-Registered
Labs by Location Type - Physician's Office-Based, Skilled
Nursing Facility, Home Health Agency, Hospital-Based,
Community Clinics, and Others (includes corresponding
Graph/Chart) III-14
Other Issues in Medical Lab Testing III-14
Direct Access Testing Falls under CLIA Scanner III-14
Certified, and Qualified Lab Personnel Eligible for US
Medical Labs III-14
FDA Intends to Regulate LDTs as Medical Devices III-15
Strategic Corporate Developments III-15
Accreditations/Approvals/Certifications III-26
Product Launches III-27
Key Players III-32
B.Market Analytics III-40
Table 19: US Recent Past, Current and Future Analysis for
Medical Laboratories by Location Type - Hospital-Based, and
Others Independently Analyzed with Annual Revenue Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-40
Table 20: US Historic Review for Medical Laboratories by
Location Type - Hospital-Based, and Others Independently
Analyzed with Annual Revenue Figures in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-41
Table 21: US 15-Year Perspective for Medical Laboratories by
Location Type - Percentage Breakdown of Revenues for
Hospital-Based, and Others Markets for Years 2004, 2011 and
2018 (includes corresponding Graph/Chart) III-42
2. CANADA III-43
A.Market Analysis III-43
Current and Future Analysis III-43
Medical Labs Encounter Shrinking Lab Test Budgets and
Increasing Lab Test Utilization III-43
Regulatory Scenario in Canada III-43
Accreditation Canada III-43
Standards Council of Canada III-45
Recent Accreditation III-46
Strategic Corporate Developments III-47
Product Innovations/Introductions III-50
Key Players III-51
B.Market Analytics III-52
Table 22: Canadian Recent Past, Current and Future Analysis
for Medical Laboratories by Location Type - Hospital-Based,
and Others Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-52
Table 23: Canadian Historic Review for Medical Laboratories
by Location Type - Hospital-Based, and Others Independently
Analyzed with Annual Revenue Figures in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-53
Table 24: Canadian 15-Year Perspective for Medical
Laboratories by Location Type - Percentage Breakdown of
Revenues for Hospital-Based, and Others Markets for Years
2004, 2011 and 2018 (includes corresponding Graph/Chart) III-54
3. JAPAN III-55
A.Market Analysis III-55
Demographics Drive Japanese Medical Laboratory Industry III-55
Strategic Corporate Developments III-55
B.Market Analytics III-56
Table 25: Japanese Recent Past, Current and Future Analysis
for Medical Laboratories by Location Type - Hospital-Based,
and Others Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-56
Table 26: Japanese Historic Review for Medical Laboratories
by Location Type - Hospital-Based, and Others Independently
Analyzed with Annual Revenue Figures in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-57
Table 27: Japanese 15-Year Perspective for Medical
Laboratories by Location Type - Percentage Breakdown of
Revenues for Hospital-Based, and Others Markets for Years
2004, 2011 and 2018 (includes corresponding Graph/Chart) III-58
4. EUROPE III-59
A.Market Analysis III-59
Current and Future Analysis III-59
Germany - The Largest and the Fastest Growing Market III-59
Analysis by Location Type III-59
Accreditation and Regulatory Scenario in the EU III-59
B.Market Analytics III-60
Table 28: European Recent Past, Current and Future Analysis
for Medical Laboratories by Region/Country - France,
Germany, Italy, the UK, Spain, Russia, and Rest of Europe
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-60
Table 29: European Historic Review for Medical Laboratories
by Region/Country - France, Germany, Italy, the UK, Spain,
Russia, and Rest of Europe Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2004 through
2009 (includes corresponding Graph/Chart) III-61
Table 30: European 15-Year Perspective for Medical
Laboratories by Region/Country - Percentage Breakdown of
Revenues for France, Germany, Italy, the UK, Spain, Russia,
and Rest of Europe for Years 2004, 2011 and 2018 (includes
corresponding Graph/Chart) III-62
Table 31: European Recent Past, Current and Future Analysis
for Medical Laboratories by Location Type - Hospital-Based,
and Other Medical Laboratories Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-63
Table 32: European Historic Review for Medical Laboratories
by Location Type - Hospital-Based, and Other Medical
Laboratories Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-64
Table 33: European 15-Year Perspective for Medical
Laboratories by Location Type - Percentage Breakdown of
Revenues for Hospital-Based, and Other Medical Laboratories
for Years 2004, 2011 and 2018 (includes corresponding
Graph/Chart) III-65
4a. FRANCE III-66
A.Market Analysis III-66
Current and Future Analysis III-66
Regulatory Scenario in France III-66
B.Market Analytics III-67
Table 34: French Recent Past, Current and Future Analysis
for Medical Laboratories by Location Type - Hospital-Based,
and Others Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-67
Table 35: French Historic Review for Medical Laboratories by
Location Type - Hospital-Based, and Others Independently
Analyzed with Annual Revenue Figures in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-68
Table 36: French 15-Year Perspective for Medical
Laboratories by Location Type - Percentage Breakdown of
Revenues for Hospital-Based, and Others Markets for Years
2004, 2011 and 2018 (includes corresponding Graph/Chart) III-69
4b. GERMANY III-70
A.Market Analysis III-70
Current and Future Analysis III-70
Regulatory Scenario in Germany III-70
DAkkS GmbH - Germany's National Accreditation Body III-70
Strategic Corporate Developments III-70
B.Market Analytics III-72
Table 37: German Recent Past, Current and Future Analysis
for Medical Laboratories by Location Type - Hospital-Based,
and Others Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-72
Table 38: German Historic Review for Medical Laboratories by
Location Type - Hospital-Based, and Others Independently
Analyzed with Annual Revenue Figures in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-73
Table 39: German 15-Year Perspective for Medical
Laboratories by Location Type - Percentage Breakdown of
Revenues for Hospital-Based, and Others Markets for Years
2004, 2011 and 2018 (includes corresponding Graph/Chart) III-74
4c. ITALY III-75
A.Market Analysis III-75
Current and Future Analysis III-75
ACCREDIA - The Italian Accreditation Body III-75
B.Market Analytics III-76
Table 40: Italian Recent Past, Current and Future Analysis
for Medical Laboratories by Location Type - Hospital-Based,
and Others Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-76
Table 41: Italian Historic Review for Medical Laboratories
by Location Type - Hospital-Based, and Others Independently
Analyzed with Annual Revenue Figures in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-77
Table 42: Italian 15-Year Perspective for Medical
Laboratories by Location Type - Percentage Breakdown of
Revenues for Hospital-Based, and Others Markets for Years
2004, 2011 and 2018 (includes corresponding Graph/Chart) III-78
4d. THE UNITED KINGDOM III-79
A.Market Analysis III-79
Current and Future Analysis III-79
Medical Laboratories Encounter Roadblocks in the UK III-79
UKAS - The Sole National Accreditation Body in the UK III-79
Strategic Corporate Developments III-80
B.Market Analytics III-81
Table 43: UK Recent Past, Current and Future Analysis for
Medical Laboratories by Location Type - Hospital-Based, and
Others Independently Analyzed with Annual Revenue Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-81
Table 44: UK Historic Review for Medical Laboratories by
Location Type - Hospital-Based, and Others Independently
Analyzed with Annual Revenue Figures in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-82
Table 45: UK 15-Year Perspective for Medical Laboratories by
Location Type - Percentage Breakdown of Revenues for
Hospital-Based, and Others Markets for Years 2004, 2011 and
2018 (includes corresponding Graph/Chart) III-83
4e. SPAIN III-84
A.Market Analysis III-84
Current and Future Analysis III-84
ENAC III-84
B.Market Analytics III-85
Table 46: Spanish Recent Past, Current and Future Analysis
for Medical Laboratories by Location Type - Hospital-Based,
and Others Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-85
Table 47: Spanish Historic Review for Medical Laboratories
by Location Type - Hospital-Based, and Others Independently
Analyzed with Annual Revenue Figures in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-86
Table 48: Spanish 15-Year Perspective for Medical
Laboratories by Location Type - Percentage Breakdown of
Revenues for Hospital-Based, and Others Markets for Years
2004, 2011 and 2018 (includes corresponding Graph/Chart) III-87
4f. RUSSIA III-88
Market Analysis III-88
Table 49: Russian Recent Past, Current and Future Analysis
for Medical Laboratories by Location Type - Hospital-Based,
and Others Independently Analyzed with Annual Revenue
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-88
Table 50: Russian Historic Review for Medical Laboratories
by Location Type - Hospital-Based, and Others Independently
Analyzed with Annual Revenue Figures in US$ Million for
Years 2004 through 2009 (includes corresponding Graph/Chart) III-89
Table 51: Russian 15-Year Perspective for Medical
Laboratories by Location Type - Percentage Breakdown of
Revenues for Hospital-Based, and Others Markets for Years
2004, 2011 and 2018 (includes corresponding Graph/Chart) III-90
4g. REST OF EUROPE III-91
A.Market Analysis III-91
Current and Future Analysis III-91
Strategic Corporate Developments III-91
Product Innovations/Introductions III-93
B.Market Analytics III-94
Table 52: Rest of Europe Recent Past, Current and Future
Analysis for Medical Laboratories by Location Type -
Hospital-Based, and Others Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-94
Table 53: Rest of Europe Historic Review for Medical
Laboratories by Location Type - Hospital-Based, and Others
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-95
Table 54: Rest of Europe 15-Year Perspective for Medical
Laboratories by Location Type - Percentage Breakdown of
Revenues for Hospital-Based, and Others Markets for Years
2004, 2011 and 2018 (includes corresponding Graph/Chart) III-96
5. ASIA-PACIFIC III-97
A.Market Analysis III-97
Current and Future Analysis III-97
APLAC - The Sole Regional Accreditation Body in Asia-Pacific III-97
Notable Markets in the Region III-98
Australia III-98
Current Market Scenario III-98
Strong Growth in Lab Testing Leads to Increased Private
Health Insurance Premiums III-98
NATA - An Australian Regulatory Agency III-98
China III-99
Privatization of Hospitals to Spur Growth of Testing
Facilities in China III-99
Myriad of Factors Propel Medical Laboratory Market III-99
Reimbursement and Insurance Scenario in China III-100
CNAL - The National Accreditation Body in China III-100
HKAS - An Accreditation Body in Hong Kong III-100
India III-101
Levels of Medical Laboratories III-101
Primary Level III-101
Secondary Level III-102
Tertiary Level III-102
Table 55: Indian Medical Laboratories Market (2010):
Percentage Share Breakdown of Revenues by Type of Lab -
High-End Labs, Regional Labs, and Manual Labs (includes
corresponding Graph/Chart) III-102
Table 56: Indian Medical Laboratories Market by
Therapeutic Area (2009): Percentage Share Breakdown of
Revenues for Biochemistry, Immunology, Hematology, and
Others (includes corresponding Graph/Chart) III-103
Growth Drivers III-103
Challenges III-103
Competitive Landscape III-103
Business Model of Indian Medical Labs III-104
Table 57: Indian Medical Laboratories Market (2009):
Number of Labs and Collection Centers Operated by -
Piramal Diagnostic, Metropolis, SRL Diagnostics, and Dr.
Lal Path Labs (includes corresponding Graph/Chart) III-105
Regulatory Scenario in India III-105
Indonesia III-105
Market Overview III-105
Regulatory Scenario in Indonesia III-106
Korea III-106
Rapidly Aging Korean Population Spurs Demand for Clinical
Lab Testing III-106
Table 58: South Korean Medical Laboratories Market
(2010): Percentage Share Breakdown of Medical
Laboratories by Healthcare Segment - Immunochemistry,
Infectious Disease, Clinical Chemistry, Microbiology,
Hematology, Molecular Biology, and Others (includes
corresponding Graph/Chart) III-106
KOLAS - The National Accreditation Agency of Korea III-107
Philippines III-107
Regulatory Scenario in Philippines III-107
Singapore III-107
SAC - The National Agency for Accreditation in Singapore III-107
Thailand III-108
BLQS - A Designated Accreditation Authority in Thailand III-108
Strategic Corporate Developments III-108
Key Players III-111
B.Market Analytics III-113
Table 59: Asia-Pacific Recent Past, Current and Future
Analysis for Medical Laboratories by Location Type -
Hospital-Based, and Others Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-113
Table 60: Asia-Pacific Historic Review for Medical
Laboratories by Location Type - Hospital-Based, and Others
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-114
Table 61: Asia-Pacific 15-Year Perspective for Medical
Laboratories by Location Type - Percentage Breakdown of
Revenues for Hospital-Based, and Others Markets for Years
2004, 2011 and 2018 (includes corresponding Graph/Chart) III-115
6. LATIN AMERICA III-116
A.Market Analysis III-116
Current and Future Analysis III-116
Brazil III-116
INMETRO - The National Accreditation Body of Brazil III-116
Strategic Corporate Development III-117
B.Market Analytics III-117
Table 62: Latin American Recent Past, Current and Future
Analysis for Medical Laboratories by Location Type -
Hospital-Based, and Others Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-117
Table 63: Latin American Historic Review for Medical
Laboratories by Location Type - Hospital-Based, and Others
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-118
Table 64: Latin American 15-Year Perspective for Medical
Laboratories by Location Type - Percentage Breakdown of
Revenues for Hospital-Based, and Others Markets for Years
2004, 2011 and 2018 (includes corresponding Graph/Chart) III-119
7. REST OF WORLD III-120
A.Market Analysis III-120
Current and Future Analysis III-120
Notable Markets III-120
South Africa III-120
Regulatory Environment in South Africa III-120
Zimbabwe III-120
Zimbabwean Medical Lab Services and Systems Suffer Grave
Setbacks III-120
ZINQAP - A Ray of Hope for Medical Lab Industry in Zimbabwe III-121
Strategic Corporate Development III-121
Key Players III-122
B.Market Analytics III-123
Table 65: Rest of World Recent Past, Current and Future
Analysis for Medical Laboratories by Location Type -
Hospital-Based, and Others Independently Analyzed with
Annual Revenue Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-123
Table 66: Rest of World Historic Review for Medical
Laboratories by Location Type - Hospital-Based, and Others
Independently Analyzed with Annual Revenue Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-124
Table 67: Rest of World 15-Year Perspective for Medical
Laboratories by Location Type - Percentage Breakdown of
Revenues for Hospital-Based, and Others Markets for Years
2004, 2011 and 2018 (includes corresponding Graph/Chart) III-125
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 162 (including Divisions/Subsidiaries - 173)
The United States (124)
Canada (13)
Japan (1)
Europe (14)
- Germany (2)
- The United Kingdom (5)
- Rest of Europe (7)
Asia-Pacific (Excluding Japan) (14)
Africa (4)
Middle East (3)
To order this report:
In_Vitro_Diagnostic Industry: Global Medical Laboratories Industry
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article